UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (S1), p.61-70

Perou, Charles M.

2011

Volltextzugriff (PDF)

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2010-11, Vol.15 (S5), p.39-48

Perou, Charles M.

2010

Volltextzugriff (PDF)

Deconstructing the molecular portraits of breast cancer

Molecular oncology, 2011-02, Vol.5 (1), p.5-23

2011

Volltextzugriff (PDF)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Breast cancer research : BCR, 2010-09, Vol.12 (5), p.R68-R68, Article R68

2010

Volltextzugriff (PDF)

SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references

Briefings in bioinformatics, 2021-01, Vol.22 (1), p.416-427

2021

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Volltextzugriff (PDF)

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Journal of clinical oncology, 2015-01, Vol.33 (1), p.13-21

2015

Volltextzugriff (PDF)

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling

BMC genomics, 2014-06, Vol.15 (1), p.419-419, Article 419

2014

Volltextzugriff (PDF)

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

Nature genetics, 2014-10, Vol.46 (10), p.1051-1059

2014

Volltextzugriff (PDF)

The genomic landscape of breast cancer as a therapeutic roadmap

Cancer discovery, 2013-01, Vol.3 (1), p.27-34

2013

Volltextzugriff (PDF)

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

PloS one, 2012-05, Vol.7 (5), p.e36530-e36530

2012

Volltextzugriff (PDF)

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Radiology, 2016-11, Vol.281 (2), p.382-391

2016

Volltextzugriff (PDF)

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Cell reports (Cambridge), 2015-12, Vol.13 (11), p.2353-2361

2015

Volltextzugriff (PDF)

Practical implications of gene-expression-based assays for breast oncologists

Nature reviews. Clinical oncology, 2012-01, Vol.9 (1), p.48-57

2012

Volltextzugriff (PDF)

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Volltextzugriff (PDF)

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2013-02, Vol.18 (2), p.123-133

2013

Volltextzugriff (PDF)

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

JNCI : Journal of the National Cancer Institute, 2016-11, Vol.108 (11), p.djw144

2016

Volltextzugriff (PDF)

Mammary development meets cancer genomics

Nature medicine, 2009-08, Vol.15 (8), p.842-844

2009

Volltextzugriff (PDF)

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Journal of clinical oncology, 2013-01, Vol.31 (2), p.203-209

2013

Volltextzugriff (PDF)

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Nature communications, 2018-03, Vol.9 (1), p.1059-14, Article 1059

2018

Volltextzugriff (PDF)

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

BMC genomics, 2011-01, Vol.4 (1), p.3-3, Article 3

2011

Volltextzugriff (PDF)

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Cell, 2019-11, Vol.179 (5), p.1191-1206.e21

2019

Volltextzugriff (PDF)

Improved indel detection in DNA and RNA via realignment with ABRA2

Bioinformatics (Oxford, England), 2019-09, Vol.35 (17), p.2966-2973

2019

Volltextzugriff (PDF)

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1168-1176

2009

Volltextzugriff (PDF)

1 – 25 von 718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(702)
Mit Volltextzugriff
(649)

Publikationsform

Sprache

Englisch
(717)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(441)
Humans
(382)
Life Sciences & Biomedicine
(378)
Female
(299)
Oncology
(236)
Breast Cancer
(221)
Tumors
(187)
Breast Neoplasms - Genetics
(183)
Gene Expression
(147)
Breast Neoplasms - Pathology
(138)
Animals
(118)
Mice
(103)
Middle Aged
(94)
Gene Expression Profiling
(91)
Biological And Medical Sciences
(90)
Cell Biology
(85)
Breast Neoplasms - Metabolism
(84)
Cancer
(84)
Breast Neoplasms - Drug Therapy
(82)
Gene Expression Regulation, Neoplastic
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Molecular Stratification of Triple‐Negative Breast Cancers

Molecular Stratification of Triple‐Negative Breast Cancers

Deconstructing the molecular portraits of breast cancer

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

The genomic landscape of breast cancer as a therapeutic roadmap

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Practical implications of gene-expression-based assays for breast oncologists

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

Mammary development meets cancer genomics

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Improved indel detection in DNA and RNA via realignment with ABRA2

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Suchergebnisse filtern